Viatris | VTRS - Pre Tax Profit

Stock Price
13.58
Daily Change
0.01 0.07%
Monthly
-3.55%
Yearly
87.05%
Q2 Forecast
13.04

Viatris reported $-7.9M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -7.9M 209.2M Sep/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025